The Calmer Co International Limited (ASX: CCO) has successfully completed its renounceable rights issue, raising $1,817,935 before costs. This capital raise results in the issuance of 1,817,934,217 new fully paid ordinary shares and 945,273,319 options, exercisable at $0.002 with a 20 February 2029 expiry. These new options are anticipated to be quoted on the ASX under the code CCOO. The Calmer Co. International Limited is a fast-growing beverage business leveraging a global opportunity in kava and other natural products that replace alcohol and support relaxation and sleep, delivering products through e-commerce and blue-chip retail distribution partners.
The offer saw strong participation, with eligible company directors and management taking up their entitlements, signalling their confidence. Convertible note holders applied for $365,000, reducing outstanding notes to $1,035,000. Of the total funds raised, $1,240,519 stemmed from rights taken up, and $577,416 was secured through the shortfall. Mahe Capital Pty Ltd served as Lead Manager and Underwriter. New securities are expected to be issued on Wednesday, 2 September 2026, adhering to the Prospectus timetable.
Net proceeds are allocated to build inventory for the wholesale channel, expand the Coles ranging of FZZR® products, and support general working capital. Directors will continue collaborating with Mahe Capital to place any remaining shortfall over the next three months. This aligns with recent business developments, including a Heads of Agreement for a strategic manufacturing and sales alliance, a long-term strategic supply agreement for premium noble kava, and exclusive distribution rights for kava extract ingredients worth up to $25 million in sales over three years. Furthermore, the company is finalising arrangements for FZZR® products to debut in Coles stores in October 2026.
